e-Drug3D

1723

PERAMIVIR


INN
PERAMIVIR

cas 330600-85-6
CLASS

ANTIINFECTIVES
INFLUENZA VIRUS NEURAMINIDASE INHIBITOR

ROUTE (list)

INTRAVENOUS

ATC code

J05AH03

PK parameters

Tmax 0.5 HOUR
VD 12.5 LITER
Cl 0.43 LITER / HOUR (EQN)
PPB 30 PERCENT
t1/2 20 HOUR

Target

TARGET NEURAMINIDASE

PDB
3K39 (CRYSTAL STRUCTURE OF B, PERTH NEURAMINIDASE D197E MUTANT IN COMPLEX WITH PERAMIVIR)

Ligand code = BCZ (link to the list of PDB complexes)

Download experimental 3D coordinates of BCZ with added hydrogens

DrugCentral

Neuraminidase UNIPROT P03468

Neuraminidase UNIPROT P03474

Download SDF file Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-

Formula:
C15H28N4O4

Calculated chemical properties:

MW 328.41
NB_atoms 23
XLogP -3.29
PSA 129.225
NB_HD 7
NB_HA 7
fsp3 0.80
Lipinski(0=no;1=yes) 0

FDA
NDA 206426 (label) INN (PERAMIVIR) RAPIVAB (BIOCRYST) APPROVAL= AP YEAR= 2014 NEWMOLECULARENTITY

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL